Hib-MenCY-TT (MenHibrix)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hib-MenCY-TT (MenHibrix), covering 2018-06-26 to 2018-06-26. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age [Phase 3]